These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 678425)

  • 1. Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route.
    Laursen ML; Laursen K
    Br J Cancer; 1978 Jun; 37(6):1039-45. PubMed ID: 678425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of salicyl-azo-sulfapyridine on the immune response to antigenic tumour cells inoculated into the coecal lumen of C3H mice.
    Laursen ML
    Scand J Gastroenterol; 1978; 13(8):991-7. PubMed ID: 31676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of a cellular immune response in a highly cancer-susceptible C3H/He strain of mice and its nonfactor substrain C3H/f after the transplantation of a syngeneic mammary gland tumor].
    Razvorotneva VA; Lavrovskiĭ VA; Viksler VKh; Iurchenko IuA; Gruntenko EV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):68-73. PubMed ID: 228516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary tumor immune enhancement in mice by local hyperemia.
    Vaage J
    Cancer Res; 1986 Jan; 46(1):386-9. PubMed ID: 3940204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the immunologic specificity of the macrophage-electrophoresis mobility test in mice with syngeneic and allogeneic transplants of mammary carcinoma].
    Kotzsch M; Irmscher J; Fischer R; Heidl G; Müller M
    Acta Biol Med Ger; 1976; 35(12):1749-53. PubMed ID: 69378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of "eclipsed" lymphoid cells from advanced tumor-bearing mice through adoptive transfer to sublethally irradiated syngeneic hosts.
    Youn JK; Le Francois D; Hue G; Santillana M; Barski G
    Int J Cancer; 1975 Oct; 16(4):629-38. PubMed ID: 1176209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of a tumour in F1 mice partially inhibits the GvH reaction following injection of parental spleen cells.
    Whitmarsh-Everiss T; Symes MO
    Br J Cancer; 1981 Mar; 43(3):305-11. PubMed ID: 7225282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
    Thomson AW; Cruickshank N; Fowler EF
    Br J Cancer; 1979 May; 39(5):598-602. PubMed ID: 486317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ambiguous action of splenocytes from tumor-bearing mice on the formation of metastases in the lungs of mice in an adaptive transfer system].
    Iunker VM; Arkhipov SA; Gruntenko EV
    Biull Eksp Biol Med; 1984 Nov; 98(11):598-600. PubMed ID: 6509179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic aspects of fibrosis in mouse mammary carcinomas.
    Vaage J
    Int J Cancer; 1992 Jan; 50(1):69-74. PubMed ID: 1728615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on the protection by an F1 tumour against GvHR induced in F1 mice by injection of parental spleen cells.
    Palmer DB; Whitmarsh-Everiss T; Symes MO
    Br J Cancer; 1982 Aug; 46(2):300-3. PubMed ID: 7150479
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of in situ and peripheral host immunity to syngeneic tumours employing the multicellular spheroid model.
    Lord EM
    Br J Cancer Suppl; 1980 Apr; 4():123-7. PubMed ID: 6932915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological enhancement induced by gastrointestinal immunization of mice pretreated with cyclophosphamide.
    Laursen ML
    J Cancer Res Clin Oncol; 1980; 96(3):231-41. PubMed ID: 7000791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-immunity between syngeneic tumors in mice immunized with gamma-irradiated ascites tumors.
    Kudo H; Waga T; Sato T; Ogasawara M; Ito I; Usubuchi I
    Tohoku J Exp Med; 1980 Jul; 131(3):285-8. PubMed ID: 7414608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum therapy for radiation-induced impairment of immune resistance to metastasis.
    Vaage J; Agarwal S
    Cancer Res; 1977 Oct; 37(10):3556-60. PubMed ID: 908007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing transplantation characteristics with serial in vivo passage of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1978 Oct; 38(10):3264-8. PubMed ID: 688216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor specificity, serum inhibition, and influence of regional lymph nodes on cytotoxic macrophages from cultured bone marrow.
    Fisher B; Hanlon JT; Linta J; Saffer E
    Cancer Res; 1977 Oct; 37(10):3628-33. PubMed ID: 908011
    [No Abstract]   [Full Text] [Related]  

  • 20. The induction of immunity against tumor cell transplantation with a complex of tumor cell surface substance and a serum component found in the tumor-regressor animals.
    Egawa K; Tanino T
    Int J Cancer; 1976 Jun; 17(6):725-9. PubMed ID: 947852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.